ARTICLE | Clinical News
Acanya gel regulatory update
October 27, 2008 7:00 AM UTC
FDA approved an NDA from Dow for topical Acanya gel to treat acne vulgaris in patients 12 years and older. Acanya is a combination of clindamycin phosphate 1.2% and benzoyl peroxide 2.5% in a gel. ...